AT
Affinia Therapeutics Inc.
SEC filingOther · Waltham, MA
Amount raised$13.3Msold at filing
Total offering$45M$31.7M still open
Investors in the raise20count reported to the SEC
FiledOct 14, 2025first sale Sep 16, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Carole FaigDirector
Rami DaoudExecutive Officer
Robert WeisskoffDirector
Diana BrainardDirector
Rick ModiExecutive Officer, Director
David GrayzelDirector
Luc VandenbergheDirector
Elliott SigalDirector
Edward MathersDirector
Sean NolanDirector
Executive officers, directors and promoters as listed on the Form D.